Indivior Pharmaceuticals Inc (INDV)
EBITDA Margin
32.81%
TTM · Period ending:
INDV EBITDA Margin
Latest reported32.81%period ending
Latest reported32.81%period ending
INDV TTM EBITDA Margin (27.97% → 32.81%)
TTM ebitda margin
High-resolution chart · PNG
INDV ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 32.8078% | |
| 27.4206% | |
| 24.5161% | |
| 26.9263% | |
| 23.9353% | |
| 7.9419% | |
| 8.7468% | |
| 6.5089% | |
| -9.0671% | |
| 7.1174% | |
| 6.1299% | |
| -24.4722% | |
| -2.2931% | |
| -3.1646% | |
| -5.0998% | |
| 27.9728% |